Skip to main content


Health

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.
604 of 1587



Newsletter Sign Up

Daily Readings

Reading 1, Ephesians 4:1-6
I, the prisoner in the Lord, urge you therefore to lead a life ... Read More

Psalm, Psalms 24:1-2, 3-4, 5-6
[Psalm Of David] To Yahweh belong the earth and all it ... Read More

Gospel, Luke 12:54-59
He said again to the crowds, 'When you see a cloud looming up ... Read More

Saint of the Day

October 24 Saint of the Day

St. Anthony Mary Claret
October 24: Claretian archbishop and founder. Anthony was born in Salient in ... Read More